These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 311803)

  • 1. Neutrophil migration-inhibition activity produced by a unique T lymphoblast cell line.
    Weisbart RH; Billing R; Golde DW
    J Lab Clin Med; 1979 Apr; 93(4):622-6. PubMed ID: 311803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for B-lymphocyte alloantigen in the production of neutrophil migration inhibition factor from T lymphocytes (NIF-T).
    Weisbart RH; Billing R
    Immunology; 1980 Apr; 39(4):577-82. PubMed ID: 6991400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphokine-like factors produced by human lymphoid cell lines with B or T cell surface markers.
    Yoshida T; Kuratsuji T; Takada A; Takada Y; Minowada J; Cohen S
    J Immunol; 1976 Aug; 117(2):548-54. PubMed ID: 781133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of leukocyte migration inhibition factor (LIF) and migration stimulation factor (MStF) by CD4+ and CD8+ human lymphocytes subsets and T-cell clones.
    Méndez-Samperio P; Jiménez-Zamudio L; Favila-Castillo L
    Rev Invest Clin; 1989; 41(2):107-15. PubMed ID: 2675234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    Kawano M; Iwato K; Kuramoto A
    J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cell lines secreting lymphokines. I. Establishment of T-T hybridomas.
    Epstein N; Gozes Y; Halmann M; Kobiler D
    Dev Biol Stand; 1987; 66():439-46. PubMed ID: 3108054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cell lines secreting lymphokines. II. BCGF production by a T hybridoma and B cell lines.
    Gozes Y; Epstein N; Halmann M; Bino T; Rosenberg H; Kobiler D
    Dev Biol Stand; 1987; 66():447-55. PubMed ID: 3495463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil stimulation and priming by direct contact with activated human T lymphocytes.
    Zhang JH; Ferrante A; Arrigo AP; Dayer JM
    J Immunol; 1992 Jan; 148(1):177-81. PubMed ID: 1309368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.
    Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J
    J Mol Cell Immunol; 1985; 2(1):17-26. PubMed ID: 2978223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).
    Shimizu K; Hirano T; Ishibashi K; Nakano N; Taga T; Sugamura K; Yamamura Y; Kishimoto T
    J Immunol; 1985 Mar; 134(3):1728-33. PubMed ID: 2981920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of lymphokines produced by human T-T hybridomas on the proliferation of normal and neoplastic B lymphocytes].
    Gambatesa V
    Medicina (Firenze); 1989; 9(2):184-7. PubMed ID: 2811645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous production of lymphocyte migration inhibitory factor (sLyMIF) by T and B lymphocytes from peripheral rabbit blood.
    Skopińska E; Lukasik R
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):43-8. PubMed ID: 7025792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production.
    Woody JN; Ahmed A; Knudsen RC; Strong DM; Sell KW
    J Clin Invest; 1975 May; 55(5):956-66. PubMed ID: 1091657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a B cell-derived growth-enhancing factor produced by a human B cell line established from a patient with rheumatoid arthritis.
    Kang H; Koyasu S; Takei M; Tomura K; Karasaki M; Yahara I; Sawada S
    J Immunol; 1987 Aug; 139(4):1154-60. PubMed ID: 3497197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive factor produced by a B cell line derived from an adult T cell leukemia patient.
    Mori N; Yamashita U; Tanaka Y; Nagata K; Nakata K; Oda S; Eto S
    Int J Hematol; 1992 Aug; 56(1):29-39. PubMed ID: 1391804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired cellular interactions involving lymphocytes from patients with chronic lymphocytic leukemia and ataxia-telangiectasia.
    Weisbart RH; Kacena A; Golde DW; Costea NV
    J Lab Clin Med; 1980 Jul; 96(1):114-8. PubMed ID: 6993592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine production by human T cell hybridomas.
    Le J; Vilcek J; Sadlik JR; Cheung MK; Balazs I; Sarngadharan MG; Prensky W
    J Immunol; 1983 Mar; 130(3):1231-5. PubMed ID: 6401782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the production of MIF and mitogenic factor using highly purified human T and B lymphocytes.
    Rocklin RE; Chess L; MacDermott RP; Schlossman SF; David JR
    Rheumatology; 1975; 6():98-105. PubMed ID: 1105751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.